Jafron Biomedical Co.,Ltd. Stock
Equities
300529
CNE100002995
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.93 CNY | +0.45% | -1.26% | +30.14% |
Sales 2024 * | 2.88B 398M | Sales 2025 * | 3.68B 510M | Capitalization | 22.41B 3.1B |
---|---|---|---|---|---|
Net income 2024 * | 818M 113M | Net income 2025 * | 1.05B 145M | EV / Sales 2024 * | 7.79 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.09 x |
P/E ratio 2024 * |
28.5
x | P/E ratio 2025 * |
22.3
x | Employees | 2,408 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.14% |
1 day | +0.45% | ||
1 week | -1.26% | ||
Current month | +5.05% | ||
1 month | +28.58% | ||
3 months | +41.33% | ||
6 months | +26.00% | ||
Current year | +30.14% |
Managers | Title | Age | Since |
---|---|---|---|
Fan Dong
CEO | Chief Executive Officer | 54 | 98-12-31 |
Yao Hong Chen
BRD | Director/Board Member | 45 | 12-12-31 |
Feng Li
BRD | Director/Board Member | 54 | 09-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Guo Qing Guo
BRD | Director/Board Member | 62 | 23-04-20 |
Yan Jun Xu
BRD | Director/Board Member | 51 | 23-04-20 |
Fan Dong
CEO | Chief Executive Officer | 54 | 98-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 2 M€ | -12.23% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 28.93 | +0.45% | 5,614,133 |
24-05-16 | 28.8 | -1.03% | 8,226,183 |
24-05-15 | 29.1 | -4.50% | 11,205,960 |
24-05-14 | 30.47 | +2.66% | 12,720,260 |
24-05-13 | 29.68 | +1.30% | 11,164,030 |
End-of-day quote Shenzhen S.E., May 16, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.14% | 3.1B | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.52% | 42.73B | |
+25.54% | 32.52B | |
+17.85% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- 300529 Stock